Aboul-Enein, H
Psilocybin: a pharmacological profile
American Journal of Pharmacy 146: 91-95 (1974).

Agurrel, S. and J.L.G. Nilsson
A Biosynthetic Sequence from Tryptophan to Psilocybin
Tetrahedron Letters 9: 1063-1064 (1968)

Agurrel, S. and J.L.G. Nilsson
Biosynthesis of Psilocybin: Part II. Incorporation of Labelled Tryptamine Derivatives
Acta Chemica Scandinavica 22(4): 1210-1218 (1968)

Benedict, R.G. and V.E. Tyler
Blueing in Conocybe, Psilocybe, and a Stropharia Species and the Detection of Psilocybin
Lloydia 30(2): 149-157 (1967)

Brack, A. and A. Hofmann
Tryptophan als biogenetische Vorstufe des Psilocybins
Archiv der Pharmazie 294(4): 230-234 (1961)

Fischer, R. and R. Fox
Creative Performance and the Hallucinogenic Drug-Induced Creative Experience
Journal of Psychedelic Drugs 5(1): 29-36 (1972)

Hofmann, A.
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen
Helvetica Chemica Acta 42: 1557-1572 (1959)

Hofmann, A. (Translation by J. Ott)
LSD: My Problem Child
Translator's preface by J. Ott, pp. vii-viii. McGraw-Hill, New York (1980)

Hofmann, A.
Ride through the Sierra Mazateca in search of the magic plant Ska Maria Pastora
In: Riedlinger, T.J. (Ed.) The Sacred Mushroom Seeker: Essays for R. Gordon Wasson.
Ethnomycological Studies No. 11, pp.115-127.
Dioscorides Press, Portland, OR (1990)

Hofmann, A. and F. Troxler
Identifizierung von Psilocybin
Experientia 15: 101-102 (1959)

Hofmann, A. et al.
Experientia
14(3): 107-109 (1958)

Horita, A.
Some biochemical studies on psilocybin and psilocin
Journal of Neuropsychiatry 4: 270-273 (1963).

Horita, A. and L.J. Weber
Dephosphorylation of psilocybin to psilocin by alkaline phosphatase
Proceedings of the Society for Experimental Biology 106(1): 32-34 (1961)

Leary, T.
Programmed communication during experiences with DMT (dimethyl-tryptamine)
Psychedelic Review 8: 83-95 (1966)

Leuner, H. and G. Baer
Two new short-acting hallucinogens of the psilocybin group
In: Bente, D. and P.B. Bradley (Eds.) Neuro-Psychopharmacology, pp. 471-474. Elsevier, Amsterdam, the Netherlands (1965)

Leung, A.Y. and A.G. Paul
Baeocystin and Norbaeocystin: New Analogs of Psilocybin from Psilocybe baeocystis
Journal of Pharmaceutical Sciences 57(10): 1667-1671 (1968)

Ott, J.
Pharmacotheon
Natural Products Co., Kennewick, WA (1996)

Pahnke, W.N.
The psychedelic mystical experience in the human encounter with death
Psychedelic Review 11: 4-13 (1971). First printed in Harvard Theological Review 62: 1-21

Repke, D.B. et al.
Psilocin analogs. I. Synthesis of 3-[2-(dialkylamino)ethyl]- and 3-[2-(cycloalkylamino)ethyl]indol-4-ols
Journal of Heterocyclic Chemistry 14: 71-74 (1977)

Repke, D.B. et al.
Psilocin analogs. II. Synthesis of 3-[2-(dialkylamino)ethyl]-,
3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols.
Journal of Heterocyclic Chemistry 18: 175-179 (1981)

Schultes, R.E. and A. Hofmann
The Botany and Chemistry of Hallucinogens
Charles C. Thomas, Springfield, IL (1973)

Shulgin, A.T. and A. Shulgin
TIHKAL - Tryptamines I Have Known and Loved
Transform Press, Berkeley, CA (1996)

Stijve, T.
Vorkommen von Serotonin, Psilocybin und Harnstoff in Panaeoloideae
Beitrage zur Kenntnis der Pilze Mitteleuropas 3: 229-234 (1987)

Strassman, R.J. and C.R. Qualls
Dose response study of N,N-dimethyltryptamine in humans I.
Neuroendocrine, autonomic, and cardiovascular effects.
Archives of General Psychiatry 51: 85-97 (1994)

Strassman, R.J. et al.
Dose response study of N,N-dimethyltryptamine in humans II.
Subjective effects and preliminary results of a new rating scale.
Archives of General Psychiatry 51: 98-108 (1994)

Tyler, V.E.
Occurrence of serotonin in a hallucinogenic mushroom
Science 128: 718 (1958).